The Enterprise Value as of June 2026 (TTM) for Alto Neuroscience, Inc. (ANRO) is 495.40M

According to Alto Neuroscience, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 495.40M. This represents a change of 137.31% compared to the average of 208.76M of the last 4 quarters.

Alto Neuroscience, Inc. (ANRO) Historical Enterprise Value (quarterly & annually)

How has ANRO Enterprise Value performed in the past?

The mean historical Enterprise Value of Alto Neuroscience, Inc. over the last ten years is 376.64M. The current 495.40M Enterprise Value has changed 13.05% with respect to the historical average. Over the past ten years (40 quarters), ANRO's Enterprise Value was at its highest in in the September 2023 quarter at 515.16M. The Enterprise Value was at its lowest in in the March 2025 quarter at -75890160.00.

Alto Neuroscience, Inc. (ANRO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Alto Neuroscience, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alto Neuroscience, Inc. (ANRO) Average Enterprise Value

How has ANRO Enterprise Value performed in the past?

The current Enterprise Value of Alto Neuroscience, Inc. (ANRO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Alto Neuroscience, Inc. (ANRO) Enterprise Value vs. Peers

How is ANRO’s Enterprise Value compared to its peers?

Alto Neuroscience, Inc.’s Enterprise Value is greater than Cellectis S.A. (304.86M), greater than AC Immune S.A. (172.37M), greater than Amarin Corporation plc (189.73M), greater than Larimar Therapeutics, Inc. (122.82M), greater than Contineum Therapeutics, Inc. Class A Common Stock (430.95M), greater than Aldeyra Therapeutics, Inc. (56.68M), less than Alpha Tau Medical Ltd. (895.61M), greater than Silence Therapeutics plc (310.47M), greater than Korro Bio, Inc. (96.75M), greater than DBV Technologies S.A. (366.68M),

Build a custom stock screener for Alto Neuroscience, Inc. (ANRO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alto Neuroscience, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alto Neuroscience, Inc. (ANRO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alto Neuroscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.